References
- The Korean Breast Cancer Society. Nationwide Korean breast cancer data of 2004. J Korean Breast Cancer Soc 2006;9:151- 161 https://doi.org/10.4048/jbc.2006.9.2.151
- Annual report of the central cancer registry in Korea (2001- 2002). Ministry of Health and Welfare. Republic of Korea 2005
- Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995;333:1456-1461 https://doi.org/10.1056/NEJM199511303332203
- Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-1241 https://doi.org/10.1056/NEJMoa022152
- Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347:1227-1232 https://doi.org/10.1056/NEJMoa020989
- Ahn SH, Yoo KY. The Korean Breast Cancer Society. Chronological changes of clinical characteristics in 31,115 new breast cancer patients amon Koreans during 1996-2004. Breast Cancer Res Treat 2006;99:209-214 https://doi.org/10.1007/s10549-006-9188-x
- Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-2106 https://doi.org/10.1016/S0140-6736(05)67887-7
- Koh KO, Kim MS, Yoo SY, et al. The results of primary radiotherapy following breast-conserving surgery for early breast cancer. J Korean Soc Ther Radiol 1995;13:163-172
- Suh CO, Chung EJ, Lee HD, Lee KS, Oh KK, Kim GE. Risk factors for recurrence after conservative treatment in early breast cancer: preliminary report. J Korean Soc Ther Radiol 1997;15:331-338
- Kim KJ, Huh SJ, Yang JH, et al. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol 2005; 35:126-133 https://doi.org/10.1093/jjco/hyi039
- Hong SG, Lee JH, Lee SK, Yoon SO. Breast-conserving surgery with or without radiation radiation therapy for early breast cancer. J Korean Surg Soc 1998;55:341-349
- Touboul E, Buffat L, Belkacémi Y. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1999;43:25-38 https://doi.org/10.1016/S0360-3016(98)00365-4
- Kurtz JM, Amalric R, Delouche G, et al. The second ten years: Long time risks of breast conservation in early breast cancer. Int J Radiat Oncol Biol Phys 1987;13:1327-1332 https://doi.org/10.1016/0360-3016(87)90224-0
- Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001; 345:1378-1387
- Bartelink H, Horiot JC, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007;25:3259-3265 https://doi.org/10.1200/JCO.2007.11.4991
- Lee SH, Lee KC, Choi J, et al. Radiation Therapy and chemotherapy after breast conserving surgery for invasive breast cancer: an interim result. J Korean Soc Ther Radiol 2007;25:16-25
- Fowble B, Solin LJ, Schultz DJ, et al. Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 1989;17:703-710 https://doi.org/10.1016/0360-3016(89)90055-2
- Halverson KJ, Taylor ME, Perez CA, et al. Regional nodal management patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 1993;26:593-599 https://doi.org/10.1016/0360-3016(93)90274-Y
- Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991;9:988-996 https://doi.org/10.1200/JCO.1991.9.6.988
- Vicini FA, Horwitz EM, Lacerna MD, et al. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 1997;39:1069-1076 https://doi.org/10.1016/S0360-3016(97)00555-5
- Fodor J, Toth J, Major T, et al. Incidence and time of occurrence of regional recurrence in Stage I-II breast cancer: value of adjuvant irradiation. Int J Radiat Oncol Biol Phys 1999;44:281-287 https://doi.org/10.1016/S0360-3016(99)00013-9
- Galper S, Recht A, Silver B, et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 1999;45:1157-1166 https://doi.org/10.1016/S0360-3016(99)00334-X
- Grills IS, Kestin LL, Goldstein N, et al. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys 2003;56:658-670 https://doi.org/10.1016/S0360-3016(03)00017-8
- Fortin A, Dagnault A, Larochelle M, Vu TT. Impact of locoregional radiotherapy in node-positive patients treated by breast-conservative treatment. Int J Radiat Oncol Biol Phys 2003;56:1013-1022 https://doi.org/10.1016/S0360-3016(03)00202-5
- Borger J, Kemperman H, Hart A, et al. Risk factors in breast conserving therapy. J Clin Oncol 1994;12:653-660 https://doi.org/10.1200/JCO.1994.12.4.653
- Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 1989;17:719-725 https://doi.org/10.1016/0360-3016(89)90057-6
- Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995;76:259-267 https://doi.org/10.1002/1097-0142(19950715)76:2<259::AID-CNCR2820760216>3.0.CO;2-2
- Kini VR, Vicini FA, Frazier R, et al. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 1999;43:341-346 https://doi.org/10.1016/S0360-3016(98)00395-2
- Anscher MS, Jones P, Prosnitz LR, et al. Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 1993;218: 22-28 https://doi.org/10.1097/00000658-199307000-00005
- DiBiase SJ, Komarnicky LT, Heron DE, et al. Influence of radiation dose on positive surgical margins in women undergoing breast conservation therapy. Int J Radiat Oncol Biol Phys 2002;53:680-686 https://doi.org/10.1016/S0360-3016(02)02761-X
- Gage I, Schnitt SJ, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996;78:1921-1928 https://doi.org/10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO;2-#
- Jobsen JJ, van der Palen J, Ong F, et al. The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys 2003;57:724-731 https://doi.org/10.1016/S0360-3016(03)00644-8
- Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999;44:1005-1015 https://doi.org/10.1016/S0360-3016(99)00112-1
- Recht A, Come SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996;334: 1356-1361 https://doi.org/10.1056/NEJM199605233342102
- Wazer D, Schmidt-Ullrich R, Ruthazer R, et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys 1999;45:885-891 https://doi.org/10.1016/S0360-3016(99)00196-0
- Robson M, Gilewski T, Haas B, et al. BRCA-associated breast cancer in young women. J Clin Oncol 1998;16:1642-1649 https://doi.org/10.1200/JCO.1998.16.5.1642
- Garber J. Inherited breast cancer: increasingly familiar territory. J Clin Oncol 1998;16:1639-1641 https://doi.org/10.1200/JCO.1998.16.5.1639
- Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-1462
- Choi DH, Lee MH, Bale AE, Carter D, Haffty BG. Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 2004;22:1638-1645 https://doi.org/10.1200/JCO.2004.04.179
- Ahn SH, Hwang UK, Kwak BS, et al. Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. J Korean Med Sci 2004;19:269-274 https://doi.org/10.3346/jkms.2004.19.2.269
- Aebi S, Gelber S, Castiglione-Gertsch M, et al. Is chemotherapy alone adequate for young women with oestrogen receptor-positive breast cancer? Lancet 2000;355:1869-1874
- Weiss RB, Woolf SH, Demakos E, et al. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracilbased adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. J Clin Oncol 2003;21:1825-1835 https://doi.org/10.1200/JCO.2003.09.006
- Chia SK, Speers CH, Bryce CJ, et al. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. J Clin Oncol 2004;22:1630-1637 https://doi.org/10.1200/JCO.2004.09.070
- Pharoah PD, Day NE, Caldas C. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer 1999;80:1968-1973 https://doi.org/10.1038/sj.bjc.6690628
- Bull SB, Ozcelik H, Pinnaduwage D, et al. The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in nodenegative breast cancer. J Clin Oncol 2004;22:86-96 https://doi.org/10.1200/JCO.2004.09.128
- Goffin JR, Chappuis PO, Begin LR, et al. Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data. Cancer 2003;97:527-536 https://doi.org/10.1002/cncr.11080
- Linderholm B, Lindh B, Tavelin B, et al. p53 and vascularendothelial- growth -factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer 2000;89:51-62 https://doi.org/10.1002/(SICI)1097-0215(20000120)89:1<51::AID-IJC9>3.0.CO;2-8
- Overgaard J, Yilmaz M, Guldberg P, et al. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node positive breast cancer. Acta Oncol 2000;39:327-333 https://doi.org/10.1080/028418600750013096
- Cuny M, Kramar A, Courjal F, et al. Relating genotype and phenotype in breast cancer: An analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Res 2000;60:1077-1083
- Harris L, Fritsche H, Mennel R, et al. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007;25: 5287-5312 https://doi.org/10.1200/JCO.2007.14.2364